To cite: Nan Y, Bai Y, Hu X, et al. Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy. Journal for ImmunoTherapy of Cancer 2024;12:e009236. doi: 10.1136/jitc-2024–0 09 236
In this article, the affiliations have been updated:
(1) Fudan University School of Pharmacy, Shanghai, China has been updated to: Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.
(2) University of Michigan, Ann Arbor, Michigan, USA has been updated to: College of Literature, Science, and the Arts, University of Michigan, Ann Arbor, Michigan, USA.
(3) Shanghai Jiao Tong University, Shanghai, China has been updated to: Department of Pharmacy, Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.